ReWalk Robotics Ltd (NASDAQ:RWLK) posted its quarterly earnings data on Thursday. The medical device company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.32) by $0.10, Briefing.com reports. ReWalk Robotics had a negative return on equity of 528.26% and a negative net margin of 389.13%. The company had revenue of $1.70 million for the quarter, compared to the consensus estimate of $1.63 million. During the same period in the previous year, the business earned ($0.62) EPS. ReWalk Robotics’s revenue for the quarter was up 21.4% compared to the same quarter last year.

ReWalk Robotics (NASDAQ RWLK) opened at $1.40 on Friday. The company has a debt-to-equity ratio of 2.51, a quick ratio of 1.58 and a current ratio of 1.87.

Several equities research analysts have issued reports on RWLK shares. Canaccord Genuity dropped their price objective on ReWalk Robotics from $4.00 to $3.00 and set a “buy” rating on the stock in a report on Friday, August 4th. Oppenheimer Holdings, Inc. set a $4.00 price objective on ReWalk Robotics and gave the stock a “buy” rating in a report on Friday, August 4th. Finally, Jefferies Group LLC dropped their price objective on ReWalk Robotics from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Friday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. ReWalk Robotics currently has a consensus rating of “Hold” and a consensus price target of $3.38.

COPYRIGHT VIOLATION WARNING: This story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.americanbankingnews.com/2017/11/02/rewalk-robotics-ltd-rwlk-posts-earnings-results-beats-expectations-by-0-13-eps.html.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Earnings History for ReWalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.